Allergic rhinitis (AR) is the most common allergic disorder in Australia.1 Despite this, it is often underdiagnosed and undertreated.1 In fact, many patients attempt to self-manage their AR even without a clinical diagnosis and often fail to recognise the severity of their symptoms.2 As a healthcare professional, you can help them effectively manage their AR by matching the right treatment for the right symptoms at the right time.1
Learn from the expert. Watch Professor Richard Harvey — Rhinologist and ENT surgeon (Sydney ENT Clinic, Darlinghurst, NSW), discuss a patient-centred approach to AR management. In a series of short videos, find out about the burden of AR; understand how to diagnose AR and differentiate it from other common upper respiratory tract infections; explore patient perspectives for treatment selection; and recognise guideline recommendations for the treatment of moderate-to-severe AR symptoms, including the role of combination treatments e.g. Dymista® 125/50.
PBS Information: This product is not listed on the PBS.
PLEASE REVIEW PRODUCT INFORMATION AVAILABLE HERE, BEFORE PRESCRIBING.
References: 1. Australiasian Society of Clinical Immunology and Allergy. Allergic rhinitis clinical update. 2020. 2. Tan R, et al. Asthma Res and Pract. 2017;3:8
Want more information on Dymista® or other Viatris products and services?